I N V E S T O R P R E S E N T A T I O N March 2022 Forward Looking Statements This presentation has been prepared by Movano Inc. ("we," "us," "our," "Movano" or the "Company") and is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of ...

Financial Data and Key Metrics Changes - Movano reported an operating loss of $6.3 million in Q4 2021, compared to an operating loss of $3.2 million in the same period last year [39] - For the full year 2021, the operating loss was $19.8 million, up from $11.1 million in 2020 [39] - The increase in losses was primarily due to team expansion, R&D initiatives, and costs associated with being a public company [40] Business Line Data and Key Metrics Changes - The company is preparing for the beta launch of its first commercial product, the Movano Ring, which is expected to be released in the second half of 2022 [12][40] - The Movano Ring will measure various health metrics and is designed specifically for women, addressing a gap in the wearable technology market [10][20] Market Data and Key Metrics Changes - Since the announcement of the Movano Ring, the company has received over 50,000 unique visitors to its website and more than 4,000 supportive messages from potential customers [17] - The media response to the Movano Ring has been overwhelmingly positive, with features in major outlets like TechCrunch and Forbes [15] Company Strategy and Development Direction - Movano aims to position itself at the intersection of medical technology and consumer devices, focusing on affordable health solutions [25][23] - The company is pursuing FDA clearances for its health monitoring capabilities, which include heart rate, blood oxygen, and respiration rate [12][54] - The strategy includes a subscription model to make the solution accessible to a wider audience while allowing for reinvestment in product features [58] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's trajectory and the market opportunity, emphasizing the importance of capital deployment and operating efficiency [42][46] - The CEO highlighted the need for healthcare to become more consumer-oriented and the potential for the Movano Ring to help a large population manage their health proactively [61][62] Other Important Information - The company has made significant progress in technology development, including the completion of critical studies for FDA clearances [26][30] - Key strategic hires have been made to strengthen the team, including individuals with experience from Google Fitbit and Medtronic [34] Q&A Session Summary Question: What is the status of cash burn rate? - The cash burn was $5.7 million in Q4, with $33.6 million in cash equivalents at year-end. The company plans to invest in R&D and team expansion as it prepares for the beta launch [45][46] Question: How did the meetings with potential strategic partners at CES go? - The Movano Ring announcement generated significant interest from potential strategic partners across healthcare, consumer, and technology sectors, exceeding expectations [47] Question: What is the status of blood pressure and glucose algorithm development? - Progress has been made, but the company is not yet ready to file for FDA clearance. The focus is on improving data accuracy and developing algorithms [48][54] Question: Can you provide details on the beta launch, including pricing and subscription model? - There is high interest in beta testing, but specific details on pricing and subscription models are not yet available. The focus will be on thorough testing before launch [55][56] Question: What are the biggest takeaways after one year as CEO? - The CEO emphasized the importance of addressing chronic health conditions and the potential for the Movano Ring to help a large audience live healthier lives [60][62]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as specified in its charter) (State of incorporation) (I.R.S. Employer Delaware 26-0579295 Identification No.) 68 ...

Movano Inc. (NASDAQ:MOVE) Q3 2021 Results Earnings Conference Call November 11, 2021 5:00 PM ET Company Participants J. Cogan - Chief Financial Officer John Mastrototaro - Chief Executive Officer Conference Call Participants Operator Greetings. Welcome to the Movano 3Q 2021 earnings conference call. At this time, all participants are in a listen only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. Please note, this conference is being recorded. I will now tu ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as specified in its charter) (State of incorporation) (I.R.S. Employer Delaware 26-0579295 Identification No.) 6800 Ko ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 26-0579295 (State of incorporation) (I.R.S. Employer Identification No.) 6800 K ...